Prime Medicine, Inc. License Agreements
8 Contracts & Agreements
- Eleventh Amendment to License Agreement, dated May 4, 2023, between Prime Medicine, Inc. and MIL 21E, LLC (Filed With SEC on August 7, 2023)
- Tenth Amendment to License Agreement, dated April 14, 2023, between Prime Medicine, Inc. and MIL 21E, LLC (Filed With SEC on August 7, 2023)
- Ninth Amendment to License Agreement, dated March 17, 2023, between Prime Medicine, Inc. and MIL 21E, LLC (Filed With SEC on August 7, 2023)
- Sixth Amendment to License Agreement, dated April 5, 2022, between Prime Medicine, Inc. and MIL 21E, LLC (Filed With SEC on August 7, 2023)
- License Agreement, dated March 16, 2020, between MIL 21E, LLC and the Registrant, as amended (Filed With SEC on September 23, 2022)
- Amendment No. 2 to License Agreement, dated February 18, 2021, between The Broad Institute, Inc. and the Registrant (Filed With SEC on September 23, 2022)
- Amendment No. 1 to License Agreement, dated May 5, 2020, between The Broad Institute, Inc. and the Registrant (Filed With SEC on September 23, 2022)
- License Agreement, dated September 26, 2019, between The Broad Institute, Inc. and the Registrant, as amended (Filed With SEC on September 23, 2022)
